Comment on the article by Dutra Medeiros et al. Entitled 'dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema'

Ophthalmologica

Volumn 233, Issue 2, 2015, Pages 117-

  Arkan Yorgun, Mücella ^a   Toklu, Yasin ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

BRANCH RETINAL VEIN OCCLUSION; CLINICAL PRACTICE; DIABETIC MACULAR EDEMA; DISEASE COURSE; DRUG IMPLANT; DRUG IMPLANTATION; HUMAN; LETTER; LOW LEVEL LASER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RECURRENT DISEASE; RETREATMENT; VISUAL ACUITY; DIABETIC RETINOPATHY; DRUG EFFECTS; FEMALE; MACULAR EDEMA; MALE; VITREOUS BODY;

DEXAMETHASONE; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA; MALE; VITREOUS BODY;

EID: 84924261258     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000371456     Document Type: Letter

References (4)

1. Dutra Medeiros M, Postorino M, Navarro R, Garcia-Arumi J, Mateo C, Corcostegui B: Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema. Ophthalmologica 2014; 231: 141-146.
2. Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C, Whitcup SM; Dexamethasone DDS Phase II Study Group: Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 2010; 128: 289-296.
3. Querques L, Querques G, Lattanzio R, Gigante SR, Del Turco C, et al: Repeated intravitreal dexamethasone implant (Ozurdex ®) for retinal vein occlusion. Ophthalmologica 2013; 229: 21-25.
4. Coscas G, Augustin A, Bandello F, de Smet MD, Lanzetta P, Staurenghi G, Parravano MC, Udaondo P, Moisseiev E, Soubrane G: Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 2014; 24: 1-9.